Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Pandion and Astellas Announce Collaboration to Deliver Pancreas-Targeted Immunomodulators

Thursday, October 31, 2019

Pandion Therapeutics Inc and Astellas Pharma Inc announced today the signing of a License and Collaboration Agreement directed toward the research development and commercialization of locally acting immunomodulators for autoimmune diseases of the pan...

Cyclo Therapeutics Signs Agreement with Worldwide Clinical Trials to Conduct Alzheimer’s Disease Clinical Trial

Thursday, October 31, 2019

Cyclo Therapeutics Inc a clinicalstage biotechnology company that develops cyclodextrinbased products for the treatment of NiemannPick Disease Type C and Alzheimers Disease today announced that it has signed an agreement with Worldwide Clinical Trial...

Gotham Therapeutics Establishes Advanced Oncology Profiling Cascade with ProQinase to Progress its Portfolio of Epitranscriptomic Drug Candidates

Wednesday, October 30, 2019

Gotham Therapeutics a biotechnology company developing a novel drug class targeting RNAmodifying proteins and ProQinase an early stage drugdiscovery company recently acquired by MalvernPAbased Reaction Biology Corp today announced that they have esta...

Pascal Biosciences and Y-Biologics Announce Research Collaboration for Development of a Bispecific Antibody for Leukemia

Wednesday, October 30, 2019

Pascal Biosciences Inc and YBiologics today announced a research collaboration agreement for the discovery and development of novel bispecific antibodies for the treatment of leukemia Under the terms of the agreement YBiologics will contribute its no...

Ziopharm Oncology and MD Anderson Cancer Center Announce New R&D Agreement to Expand TCR-T Program

Tuesday, October 29, 2019

Ziopharm Oncology Inc and The University of Texas MD Anderson Cancer Center today announced a new research and development agreement relating to Ziopharms Sleeping Beauty immunotherapy program to use nonviral gene transfer to stably express and clini...

Gilead and Glympse Bio Announce Strategic Collaboration for Use of Biomarker Technology in NASH Clinical Development

Tuesday, October 29, 2019

Gilead Sciences Inc and Glympse Bio Inc today announced that the companies have entered into a strategic collaboration in nonalcoholic steatohepatitis NASH clinical development Glympse Bios proprietary synthetic biomarkers bioengineered to identify...

HistoIndex Announces Global Partnerships To Expand AI-Based Digital Pathology Platform

Monday, October 28, 2019

HistoIndex announces the expansion of its AIbased digital pathology platform towards largescale NASH preclinical programs for pharmaceutical and biotech companies to achieve quantifiable and reproducible data on therapeutic responses in NASH animal m...

AZTherapies Strengthens Neuroinflammation-Targeted Pipeline Through Acquisition of Smith Therapeutics

Friday, October 25, 2019

AZTherapies Inc a biopharmaceutical company developing therapeutics to extend brain health today announced the acquisition of Smith Therapeutics a private biopharmaceutical company with a shared goal of targeting neuroinflammation to treat neurodegen...

AVROBIO Receives Orphan-Drug Designation from the U.S. FDA for AVR‑RD‑02 for the Treatment of Gaucher Disease

Friday, October 25, 2019

AVROBIO Inc today announced that the US Food and Drug Administration FDA has granted orphandrug designation for the Companys investigational gene therapy AVRRD for the treatment of Gaucher disease AVRRD consists of the patients own hematopoietic stem...

Pliant Therapeutics Announces Strategic Collaboration to Develop Novel Therapies for NASH and Fibrotic Diseases

Thursday, October 24, 2019

Pliant Therapeutics Inc a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis today announced it has entered into a strategic collaboration and license agreement with Novartis c...

Latest Issue
Get instant
access to our latest e-book